Articular Cartilage Injury; Current Status and Future Direction

Author:

Moradi Maryam1,Parvizpour Farzad23,Arabpour Zohreh24ORCID,Zargarzadeh Nikan5,Nazari Mahnaz6,Rashnavadi Heewa7,Sefat Farshid4,Dehghani Sanaz28,Latifi Marzieh6,Jafarian Arefeh2ORCID

Affiliation:

1. School of Public Health, Iran University of Medical Sciences, Tehran, Iran

2. Iranian Tissue Bank & Research Center, Tehran University of Medical Sciences, Tehran, Iran

3. Department of Molecular Medicine, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran

4. Department of Biomedical and Electronics Engineering, School of Engineering, University of Bradford, Bradford, UK

5. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

6. Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

7. Tehran University of Medical Sciences Medicine School Tehran Iran

8. Organ Procurement Unit, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Abstract: Today, treatments of cartilage and osteochondral lesions are routine clinical procedures. The avascular and hard-to-self-repair nature of cartilage tissue has posed a clinical challenge for the replacement and reconstruction of damaged cartilage. Treatment of large articular cartilage defects is technically difficult and complex, often accompanied by failure. Articular cartilage cannot repair itself after injury due to a lack of blood vessels, lymph, and nerves. Various treatments for cartilage regeneration have shown encouraging results, but unfortunately, none have been the perfect solution. New minimally invasive and effective techniques are being developed. The development of tissue engineering technology has created hope for articular cartilage reconstruction. This technology mainly supplies stem cells with various sources of pluripotent and mesenchymal stem cells. This article describes the treatments in detail, including types, grades of cartilage lesions, and immune mechanisms in cartilage injuries.

Publisher

Bentham Science Publishers Ltd.

Subject

General Medicine,Medicine (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3